Skip to main content


Life Sciences: 2013 Legal Developments You Need to Know About

11 February 2013
Mayer Brown Newsletter

This is a short guide outlining some of the key legal developments in the life sciences sector in 2013.

The developments include a proposed modification to the HSR Form that would impact reporting requirements, AIA’s First-Inventor-to-File provisions, Federal Circuit cases to watch, Reverse-Payment legislation, proposed State legislation concerning the substitution of biosimilar products, the US Federal Excise Tax on medical devices sales and the FDA’s draft guidance for the evaluation and labeling of abuse-deterrent opioids.

For further information or advice, please contact your usual contact at Mayer Brown or:

Christopher Mackey


  • Melissa A. Anyetei
    T +1 312 701 7103
  • Vera A. Nackovic
    T +1 312 701 8115
  • Scott P. Perlman
    T +1 202 263 3201
The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.